6.70
price down icon0.30%   -0.02
after-market Handel nachbörslich: 6.78 0.08 +1.19%
loading

Finanzdaten der Capricor Therapeutics Inc-Aktie (CAPR)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- 11.13 2.2616 3.9714
Operating Expenses
10.95%
27.72
24.98 18.83 15.27 15.56
Operating Income/Loss
10.95%
-27.72
-24.98 -7.6978 -13.01 -11.59
Nonoperating Income/Loss
205.80%
1.8083
0.5914 0.5812 0.4532 0.5914
Income/Loss From Continuing Operations Before Tax
6.23%
-25.91
-24.39 -7.1166 2.2616 -11.00
Income/Loss From Continuing Operations After Tax
6.23%
-25.91
-24.39 -7.1166 -12.56 -11.00
Net Income/Loss
6.23%
-25.91
-24.39 -7.1166 -12.56 -11.00
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.16%
45.71
45.64 3.1194 33.09 31.84
Diluted Average Shares
0.16%
45.71
45.64 3.1194 33.09 31.84
Basic Earnings Per Share
7.55%
-0.57
-0.53 -0.11 -0.38 -0.35
Diluted Earnings Per Share
7.55%
-0.57
-0.53 -0.11 -0.38 -0.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$21.75
price down icon 5.15%
$85.96
price up icon 1.45%
$32.75
price up icon 0.21%
$102.61
price up icon 0.30%
$161.38
price down icon 1.56%
biotechnology ONC
$320.94
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):